A shirt brushing your skin can feel painful even when there is no visible rash. Burning, tingling, skin pain, and unusual sensitivity to touch have been reported with Wegovy. The U.S. label groups these sensations under dysesthesia and reports them more often with Wegovy HD, the 7.2 mg weekly injection, than with the 2.4 mg weekly injection. Reports also occurred with the tablet. If the sensation is new, painful, persistent or getting worse, tell the prescribing team, including the exact semaglutide product and dose. Wegovy U.S. prescribing information, section 6.1.
What does dysesthesia feel like?
Dysesthesia means an unpleasant change in sensation. Allodynia means something normally painless, such as a bedsheet against your back, hurts. Paresthesia describes a sensation like tingling or pins and needles. These words may appear on a medication label or in a visit note. You can report what happened in your own words.
Start with what you feel and what you see. “My shirt brushing the right side of my back feels like touching a sunburn, and I can't see a rash,” gives the prescriber a location, trigger, and description. A red patch around the injection site or an ache felt deep in the muscle is a different observation. Tell the team about either if it comes with the skin sensitivity. The injection-site reaction guide and tirzepatide body aches guide cover those presentations for a different drug.
What's the evidence for Wegovy HD, the 2.4 mg shot, and the tablet?
In adult weight-management injection trials that included participants with and without type 2 diabetes, the Wegovy label reports the following percentages:
| Weekly injection group | People reporting a dysesthesia-related event |
|---|---|
| Wegovy 7.2 mg (Wegovy HD) | 22% |
| Wegovy 2.4 mg | 6% |
| Placebo | 0.3% |
These counts group related reports, including burning, tingling, skin pain and sensitivity. The injection comparisons support an association with dose. They cannot tell you whether a particular patch of painful skin comes from semaglutide.
The same label reports dysesthesia in 5% of people on the 25 mg Wegovy tablet and none on placebo in a separate tablet trial. You can use the tablet result to recognize that the symptom was reported with oral Wegovy. You cannot compare its 5% directly to the 6% for the 2.4 mg shot to decide which route is less likely to cause a problem. The groups came from different trials. These figures also do not establish a rate for Ozempic or Rybelsus. Wegovy prescribing information, sections 6.1 and 14.2.
Does the change in sensation go away?
It can improve, but the evidence gives no reliable countdown. In the higher-dose studies, most affected participants whose treatment was reduced, interrupted or stopped recovered. Among 288 people who experienced dysesthesia while taking 7.2 mg, 18% did not report recovery during the trial. That's 18% of people who reported the sensation. The trial follow-up did not establish whether symptoms later resolved for those participants. FDA label, section 6.1.
A four-person case series also described allodynia after escalation to the 2.4 mg weekly injection. Some people recovered after stopping and one who continued reported resolution after four months. That small report cannot establish a typical recovery time or whether waiting is appropriate for someone else. Share changes with your prescriber so they can assess other causes and advise you on the treatment plan.
What should you report before your next dose?
Include the medicine name and form, your current dose and date of the last increase, where and when the sensation started, and anything that triggers it. Tell the team if the area is spreading, if a rash has appeared, or if sleep, clothing, or other daily activities have become harder. For example, “It began three days after the increase. It used to hurt only where my shirt touches my shoulder, and today it hurts farther down my back.” That change is useful even if a photo still looks the same.
Ask what to do about your next scheduled dose, when to check back, and which changes should prompt you to call sooner. You do not need to take another dose or deliberately trigger the pain to confirm the pattern.
When does the Wegovy allergy warning apply?
If you develop swelling of the face, lips, tongue or throat, breathing or swallowing difficulty, severe rash or itching, fainting or dizziness, or a very rapid heartbeat, the Wegovy Medication Guide says to stop using Wegovy and get medical help right away. Call 911 for breathing difficulty, collapse, or another emergency. These symptoms need immediate assessment even if you have also had burning or tingling.

About the author
Maya Lee
Glowise Senior GLP-1 Content Editor
Maya Lee is a Glowise Health Content Editor. Her guides turn product records, authoritative sources, and everyday organization questions into clear, practical GLP-1 information.
She helps readers ask better questions and keep the details relevant to a care conversation together.
See more Glowise on Google
Add Glowise as a preferred source to find our GLP-1 guides more easily in Google Search.



